Allianz Asset Management GmbH - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 77 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Allianz Asset Management GmbH ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$494,500
+110.8%
21,5000.0%0.00%
Q4 2022$234,565
-81.9%
21,500
-86.9%
0.00%
-100.0%
Q2 2022$1,298,000
-58.7%
164,075
+23.6%
0.00%
-50.0%
Q1 2022$3,144,000
-31.8%
132,734
-1.5%
0.00%
-33.3%
Q4 2021$4,611,000
+429.4%
134,793
+174.1%
0.00%
+200.0%
Q3 2021$871,000
-73.9%
49,171
-33.8%
0.00%
-66.7%
Q2 2021$3,333,000
+73.3%
74,2600.0%0.00%
+50.0%
Q1 2021$1,923,000
+28.4%
74,2600.0%0.00%
+100.0%
Q4 2020$1,498,000
+3.2%
74,2600.0%0.00%
-50.0%
Q3 2020$1,452,000
+8.5%
74,260
-2.0%
0.00%0.0%
Q2 2020$1,338,000
+85.8%
75,790
-25.8%
0.00%
+100.0%
Q1 2020$720,000
+42.0%
102,098
+41.8%
0.00%
Q4 2019$507,000
-63.4%
72,001
-36.4%
0.00%
-100.0%
Q3 2019$1,385,000
-7.9%
113,276
-8.7%
0.00%0.0%
Q2 2019$1,503,000
+55.4%
124,090
+61.3%
0.00%0.0%
Q1 2019$967,00076,9150.00%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Pharmstandard International S.A. 750,632$7,724,00026.59%
BVF INC/IL 2,617,967$26,939,0002.37%
GREAT POINT PARTNERS LLC 982,449$10,109,0001.58%
Alambic Investment Management, L.P. 65,128$670,0000.53%
FARALLON CAPITAL MANAGEMENT LLC 2,243,202$23,083,0000.14%
ALGERT GLOBAL LLC 44,477$458,0000.10%
Monashee Investment Management LLC 42,945$442,0000.09%
Tekla Capital Management LLC 219,042$2,254,0000.08%
Spark Investment Management LLC 138,800$1,428,0000.08%
OXFORD ASSET MANAGEMENT LLP 187,653$1,904,0000.04%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders